HC Wainwright & Co. Maintains Buy on ProMIS Neurosciences, Raises Price Target to $18
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
HC Wainwright & Co. analyst Raghuram Selvaraju maintains ProMIS Neurosciences (NASDAQ:PMN) with a Buy and raises the price target from $4 to $18.
HC Wainwright & Co. analyst Raghuram Selvaraju maintains ProMIS Neurosciences (NASDAQ:PMN) with a Buy and raises the price target from $4 to $18.